| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-05 |